Can-Fite BioPharma Ltd. Lease And Sublease Payments Recognised As Expense
Can-Fite BioPharma Ltd. (CANF) reported Lease And Sublease Payments Recognised As Expense of $56.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-29.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:LeaseAndSubleasePaymentsRecognisedAsExpense · last filed 2019-03-29
| Period end | Lease And Sublease Payments Recognised As Expense 12 month |
|---|---|
| 2018-12-31 | $56.00K 20-F · filed 2019-03-29 |
| 2017-12-31 | $58.00K 20-F · filed 2019-03-29 |
| 2016-12-31 | $54.00K 6-K · filed 2018-08-08 |